Friday, July 5, 2019

Immune-boosting Compound Enhances Immunotherapy against Pancreatic Cancer

An immune-boosting compound increases the efficacy of immunotherapy against pancreatic cancer. The new drug promotes the killing of the cancer cells, resulting in the reduction of tumor size and longer life span.

from Medindia Latest Updates https://ift.tt/2YC5HaG
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

A major risk of breast cancer screening may have been overestimated for decades

A new analysis suggests mammograms may lead to far less breast cancer overdiagnosis than some earlier studies indicated. Researchers reexami...